Trial Profile
An Exploratory Trial to Evaluate the Clinical Effectiveness of a Topical Application of BMX-010 in Subjects With Rosacea
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2019
At a glance
- Drugs BMX-010 (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors BioMimetix
- 03 Jan 2019 Status changed from not yet recruiting to recruiting.
- 30 Nov 2018 New trial record